Pricing
Login
Home
Charts
Search
Watchlist
Products

Quest Laboratories Ltd

QUESTLAB
₹92.00+3.25%20 Nov 2026
Reports
Pharma Formulations

Quest Laboratories Ltd

QUESTLAB
₹92.00
+3.25%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹151Cr
Close
Close Price
₹92.00
Industry
Industry
Pharma Formulations
PE
Price To Earnings
9.47
PS
Price To Sales
1.27
Revenue
Revenue
₹118Cr
Rev Gr TTM
Revenue Growth TTM
7.51%
PAT Gr TTM
PAT Growth TTM
16.37%

Quarterly Results

Standalone
Numbers
Percentage
QuarterSep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026Sep 2026
Revenue
RevenueCr
233941424361496355
Growth YoY
Revenue Growth YoY%
81.86.33.947.514.52.813.4
Expenses
ExpensesCr
183632353257425246
Operating Profit
Operating ProfitCr
43961157119
OPM
OPM%
19.98.622.914.824.97.514.717.516.3
Other Income
Other IncomeCr
0000133-12
Interest Expense
Interest ExpenseCr
000010110
Depreciation
DepreciationCr
000000000
PBT
PBTCr
439611891010
Tax
TaxCr
112231131
PAT
PATCr
326476879
Growth YoY
PAT Growth YoY%
117.975.318.447.58.624.111.1
NPM
NPM%
12.85.515.49.117.69.116.610.916.3
EPS
EPS₹
26.919.95.93.44.63.45.04.25.5
QuarterSep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026Sep 2026
Revenue
RevenueCr
233941424361496355
Growth YoY
Revenue Growth YoY%
81.86.33.947.514.52.813.4
Expenses
ExpensesCr
183632353257425246
Operating Profit
Operating ProfitCr
43961157119
OPM
OPM%
19.98.622.914.824.97.514.717.516.3
Other Income
Other IncomeCr
0000133-12
Interest Expense
Interest ExpenseCr
000010110
Depreciation
DepreciationCr
000000000
PBT
PBTCr
439611891010
Tax
TaxCr
112231131
PAT
PATCr
326476879
Growth YoY
PAT Growth YoY%
117.975.318.447.58.624.111.1
NPM
NPM%
12.85.515.49.117.69.116.610.916.3
EPS
EPS₹
26.919.95.93.44.63.45.04.25.5

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
30596283104112118
Growth
Revenue Growth%
95.93.633.925.97.67.5
Expenses
ExpensesCr
29535467889498
Operating Profit
Operating ProfitCr
16816161820
OPM
OPM%
4.710.912.718.915.416.317.0
Other Income
Other IncomeCr
0000421
Interest Expense
Interest ExpenseCr
0011121
Depreciation
DepreciationCr
0011111
PBT
PBTCr
16714191820
Tax
TaxCr
0224534
PAT
PATCr
14510141516
Growth
PAT Growth%
526.722.9100.134.49.616.4
NPM
NPM%
2.26.98.212.213.113.313.4
EPS
EPS₹
6.138.046.86.28.39.29.7
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
30596283104112118
Growth
Revenue Growth%
95.93.633.925.97.67.5
Expenses
ExpensesCr
29535467889498
Operating Profit
Operating ProfitCr
16816161820
OPM
OPM%
4.710.912.718.915.416.317.0
Other Income
Other IncomeCr
0000421
Interest Expense
Interest ExpenseCr
0011121
Depreciation
DepreciationCr
0011111
PBT
PBTCr
16714191820
Tax
TaxCr
0224534
PAT
PATCr
14510141516
Growth
PAT Growth%
526.722.9100.134.49.616.4
NPM
NPM%
2.26.98.212.213.113.313.4
EPS
EPS₹
6.138.046.86.28.39.29.7
Sales CAGR
1 Year8%
3 Years22%
5 Years30%
TTM39%
EBITDA CAGR
1 Year14%
3 Years33%
5 Years67%
TTM8%
PAT CAGR
1 Year10%
3 Years43%
5 Years86%
TTM50%
Avg. ROCE
1 Year19%
3 Years27%
5 Years33%
TTM19%
CFO / EBITDA
1 Year-58%
3 Years-62%
5 Years-37%
TTM-

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
11112161616
Reserves
ReservesCr
591417658089
Current Liabilities
Current LiabilitiesCr
112329303714
Non Current Liabilities
Non Current LiabilitiesCr
223232
Total Liabilities
Total LiabilitiesCr
18354761122112169
Current Assets
Current AssetsCr
1227345010793
Non Current Assets
Non Current AssetsCr
6813101520
Total Assets
Total AssetsCr
18354761122112169
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
11112161616
Reserves
ReservesCr
591417658089
Current Liabilities
Current LiabilitiesCr
112329303714
Non Current Liabilities
Non Current LiabilitiesCr
223232
Total Liabilities
Total LiabilitiesCr
18354761122112169
Current Assets
Current AssetsCr
1227345010793
Non Current Assets
Non Current AssetsCr
6813101520
Total Assets
Total AssetsCr
18354761122112169

Cash Flow

Standalone
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
1343-23-11
Investing Cash Flow
Investing Cash FlowCr
-1-2-4-5-4135
Financing Cash Flow
Financing Cash FlowCr
000267-24
Net Cash Flow
Net Cash FlowCr
010040
Free Cash Flow
Free Cash FlowCr
0212-23-16
CFO To PAT
CFO To PAT%
159.984.276.929.9-171.7-71.6
CFO To EBITDA
CFO To EBITDA%
73.853.449.519.4-145.7-58.3
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
1343-23-11
Investing Cash Flow
Investing Cash FlowCr
-1-2-4-5-4135
Financing Cash Flow
Financing Cash FlowCr
000267-24
Net Cash Flow
Net Cash FlowCr
010040
Free Cash Flow
Free Cash FlowCr
0212-23-16
CFO To PAT
CFO To PAT%
159.984.276.929.9-171.7-71.6
CFO To EBITDA
CFO To EBITDA%
73.853.449.519.4-145.7-58.3

Ratios

Standalone
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
168171151
Price To Earnings
Price To Earnings
12.211.59.5
Price To Sales
Price To Sales
1.61.51.3
Price To Book
Price To Book
2.01.81.6
EV To EBITDA
EV To EBITDA
12.49.87.9
Profitability Ratios
Profitability Ratios
GPM
GPM%
17.423.731.434.922.521.821.8
OPM
OPM%
4.710.912.718.915.416.317.0
NPM
NPM%
2.26.98.212.213.113.313.4
ROCE
ROCE%
12.346.239.245.117.518.918.6
ROE
ROE%
11.141.133.435.216.615.415.0
ROA
ROA%
3.611.810.816.711.213.39.4
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
168171151
Price To Earnings
Price To Earnings
12.211.59.5
Price To Sales
Price To Sales
1.61.51.3
Price To Book
Price To Book
2.01.81.6
EV To EBITDA
EV To EBITDA
12.49.87.9
Profitability Ratios
Profitability Ratios
GPM
GPM%
17.423.731.434.922.521.821.8
OPM
OPM%
4.710.912.718.915.416.317.0
NPM
NPM%
2.26.98.212.213.113.313.4
ROCE
ROCE%
12.346.239.245.117.518.918.6
ROE
ROE%
11.141.133.435.216.615.415.0
ROA
ROA%
3.611.810.816.711.213.39.4
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr198177154151151132110
Close PriceClose₹67.20161.7018.5492.00255.24114.8744.10
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE2.7233.4111.249.4720.1317.56
Price To SalesPS2.516.980.591.270.930.513.74
RevenueRevenueCr792525911816225929
Revenue Growth TTMRev Gr TTM%-14.9%3.4%50.8%7.5%24.2%26.0%26.9%
PAT Growth TTMPAT Gr TTM%421.4%-29.6%20.1%16.4%387.4%-31.9%-48.7%
Market CapitalizationMkt CapCr198177154151151132110
Close PriceClose₹67.20161.7018.5492.00255.24114.8744.10
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE2.7233.4111.249.4720.1317.56
Price To SalesPS2.516.980.591.270.930.513.74
RevenueRevenueCr792525911816225929
Revenue Growth TTMRev Gr TTM%-14.9%3.4%50.8%7.5%24.2%26.0%26.9%
PAT Growth TTMPAT Gr TTM%421.4%-29.6%20.1%16.4%387.4%-31.9%-48.7%
Annual Reports
FY2025
FY2024
Quarterly Reports
FY2026
Sep 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Dec 25
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
ResultPPT
Transcript
Summary
Mar 25
ResultPPT
Transcript
Summary
Sep 24
ResultPPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Annual Reports
Quarterly Reports
Sep 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Dec 25
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
ResultPPT
Transcript
Summary
Mar 25
ResultPPT
Transcript
Summary
Sep 24
ResultPPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Load More
Interviews